Cytomorphology and Molecular Profile of Hyalinizing Clear Cell Carcinoma of the Lung: A Case With Mucinous Differentiation - Lin - Diagnostic Cytopathology - Wiley Online Library https://t.co/5BxT6BE9X7 🫁🔬🧬 @NU_Pathology
We are hiring! We are looking for a Director of Gastrointestinal Pathology to join our department and lead this outstanding group into the future.
Learn more and apply here: https://t.co/ntXNgDu375
Congratulations to Drs. Jeanne Camille Cardenas and Stanislav Fridland, our incoming Chief Residents! We know they will be excellent leaders in the year ahead🎉 #PurplePath
#OpenAccess | Follicular neoplasms with nuclear atypia versus other types of atypia: Should follicular neoplasms be stratified according to the presence of nuclear atypia?
https://t.co/W6lF2Zha5B
#CytoPath@JaylouVelez@Y_Tjendra
NEW in @AGA_Gastro 🎉 BiliSeq — our DNA/RNA-based NGS test for bile duct strictures — a 6-year, prospective, REAL-TIME study across 28 institutions and 2,116 patients. A thread on what we found 👇 #BiliSeq#Pathology#PancreaticCancer#Cholangiocarcinoma https://t.co/hTN7w66cR8
Another fantastic showing today by @NU_Pathology residents at #USCAP2026. Posters presented by Drs. Mohamed Amgad, Frank Rojas Alvarez, and Mark Montgomery.
#PurplePath#Pathology
Fantastic showing by @NU_Pathology residents at #USCAP2026. Monday platform presentations expertly delivered by Drs. Hugo Carillo Ng, Jon Aldinger, & Camille Cardenas
#PurplePath#Pathology
Fantastic showing by @NU_Pathology residents at #USCAP2026. Monday poster session Part 3: Drs. Gokce Deniz Ardor, Stanislav (Stas) Fridland, & Jeanne Camille Cardenas.
#PurplePath#Pathology
Fantastic showing by @NU_Pathology residents/fellows at #USCAP2026. Monday poster session Part 2: Drs. Hugo Carillo-Ng, Ahmed Mohamed 🤠, Stanislav (Stas) Fridland, and Jeanne Camille Cardenas.
#PurplePath#Pathology
Fantastic showing by @NU_Pathology residents at #USCAP2026. Monday poster session Part 1: Drs. Eric Nayman, Ivan De la Riva, Emmanuel Joshua (Shu) Garcia, & Jon Aldinger.
#PurplePath#Pathology
💥#OpenAccess! | Probability of malignancy and molecular alterations as determined by ThyroSeq v3 genomic classifier in Bethesda Category IV
https://t.co/KYRnCWiY3e
#CytoPath
For today’s #FrozenSectionFriday, all you get is a smear. For this dural-based lesion, it should be all you need! What features are shown here that help with the diagnosis? #neuropath#PathTwitter 🧠🔬
Just out in AJSP – a paper from our group describing a MAJOR new oddity.
Tumors that normally arise in the jaw from tooth🦷precursors (ameloblastoma) – but as lung primaries 🫁!
This was a neat collaboration b/w MSKCC, Mayo and UTSW where these cases were encountered independently, and we put our heads together with the help of original contributors and fellows to tackle this puzzle.
Time will tell if these are truly exceptional or have been underrecognized.
https://t.co/VVdG7wC7IG
@JLHornick@ENTpathology@MSKPathology@PulmPathSoc@yro854@thoracicpath@Path_Matt@SansanoValero@AndreMo77438628
ICYMI: Risk of malignancy of cytologic categories and post-biopsy clinical management of renal oncocytic neoplasms
https://t.co/obn1yAXGOq
@NU_Pathology#CytoPath
New publication from our department on a DNA methylation classifier to better predict meningioma recurrence risk.
Led by Drs. Sukhanova and Jamshidi with contributions from Dr. Santana dos Santos and others. #PurplePath
https://t.co/503DkkBdmE